Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
Details for Australian Patent Application No. 2003225256 (hide)
International Classifications
Event Publications
7 August 2003 Complete Application Filed
Priority application(s): 60/376,566 01.05.02 US
8 January 2004 Application Open to Public Inspection
Published as AU-B-2003225256
7 May 2009 Alteration of Name
The name of the applicant has been altered to Bayer Schering Pharma Aktiengesellschaft 2003245776 2158141 Ontario Inc. The name of the applicant has been altered to Cellometrics Inc. 2004
4 June 2009 Application Accepted
Published as AU-B-2003225256
1 October 2009 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003225257-LIGATION CLIP APPLIER AND METHOD
2003225255-Novel tissue factor targeted antibodies as anticoagulants
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser